Pay in 4 interest-free payments of $7.08 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
Kesava Reddy, G
3 RGN-259 Phase 3 Trial in Neurotrophic Keratopathy Sosne et al., International Journal of Molecular Sciences (2022) This Phase 3 randomized, placebo-controlled, double-masked clinical trial evaluated topical 0.1% RGN-259 (full-length recombinant T4 ophthalmic solution) in patients with neurotrophic keratopathy
Postprandial responses on serum metabolome to Milk and yogurt intake in young and older men
Front Immunol 8:365
US$ 23.96
US$ 20.54
US$ 23.90
US$ 24.88
US$ 26.56
US$ 27.13
US$ 21.66
US$ 24.60
US$ 23.78
US$ 27.64
US$ 22.23
US$ 29.69
US$ 22.31
